SUSD3 anticorps (AA 120-170)
Aperçu rapide pour SUSD3 anticorps (AA 120-170) (ABIN6992182)
Antigène
Voir toutes SUSD3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 120-170
-
Specificité
- SUSD3 antibody is human and mouse reactive. Multiple isoforms of SUSD3 are known to exist.
-
Purification
- SUSD3 Antibody is affinity chromatography purified via peptide column.
-
Immunogène
- SUSD3 antibody was raised against a 16 amino acid peptide from near the center of human SUSD3. The immunogen is located within amino acids 120 - 170 of SUSD3.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
SUSD3 antibody can be used for the detection of SUSD3 by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for immunocytochemistry starting at 5 μ,g/mL.
Antibody validated: Western Blot in human samples and Immunocytochemistry in mouse samples. All other applications and species not yet tested. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- SUSD3 Antibody is supplied in PBS containing 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,4 °C
-
Stockage commentaire
- SUSD3 antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
-
-
- SUSD3 (Sushi Domain Containing 3 (SUSD3))
-
Autre désignation
- SUSD3
-
Sujet
- Little is known of the function of the sushi domain containing 3 protein (SUSD3), but its expression has been reported in estrogen receptor-alpha (ERalpha)-positive breast tumors with decreased expression reported in aggressive malignant tumors (1,2). Recently, SUSD3 has been found to promote estrogen-dependent cell proliferation and may regulate cell-cell and cell-substrate interactions and migration in breast cancer (3). Furthermore, elevated SUSD3 mRNA levels were observed in aromatase inhibitor-responsive breast tumors, suggesting that it may also serve as a novel predictor of response to endocrine therapy and a potential therapeutic target (3).
-
Poids moléculaire
-
Predicted: 16, 22, 23, 28 kDa
Observed: 23 kDa -
ID gène
- 203328
-
NCBI Accession
- NP_659443
-
UniProt
- Q96L08
Antigène
-